Summary. Injection IP of insulin at a dosage of I rzg/g body weight into normal rats produced a rapid rise in serum insulin levels from < i to 298 ng/ml, and a rapid decrease in specific 125I-insulin binding to its receptors in purified liver plasma membranes. A fall in binding was seen as early as 10 minutes after injection and binding remained decreased for up to 60 rain. At 10 min, a25I-insulin binding had fallen to 59% of controls; in contrast, 125I-glucagon binding remained unchanged. Extraction of these plasma membranes followed by radioimmunoassay for insulin did not reveal appreciable amounts of exogenous insulin. The 125I-insulin dissociation rate from plasma membranes of control and insulin treated rats was the same, also indicating a lack of exogenous insulin. Scatchard analyses indicated that the decreased binding seen after insulin injection was due primarily to a change in the number of insulin receptors and not their affinity. These studies suggest, therefore, that high doses of insulin in vivo can rapidly regulate the number of plasma membrane insulin receptors in liver.
Studies in vivo and in vitro demonstrated that, in most tissues, the insulin receptor on the plasma membrane is regulated by insulin itself [1] [2] [3] . When extracellular insulin levels are increased, hormone binding to receptors decreases; conversely, when insulin levels are decreased, binding to receptors increases [1--4] . Previously, we reported that 24 hours after the injection of insulin into normal rats, the number of insulin receptors present on liver plasma membranes is decreased [5] . This finding suggested that insulin has a chronic effect on insulin receptors in vivo. Whether insulin in vivo has more rapid effects on receptor binding is unknown. Studies with lymphocytes in vitro have indicated that 30 min after incubation with unlabelled insulin, 125I-insulin binding to receptors is decreased [6] . We have investigated, therefore, whether similar acute regulation of insulin receptors also occurs in vivo.
Materials and Methods
Pork insulin (25.6U/mg) was purchased from Elanco Products Co., Indianapolis, IN, and glucagon from Sigma Chemical Co., St. Louis, MO. ~25I-insulin (800120~tCi/~tg) and lz~I-glucagon (80o100 ~tCi/gg) were prepared by stoichiometric chloramine T methods [7, 8] . The binding buffer employed in these studies contained 118 mmol/1 NaC1, 5mmol/1 KC1, 1.2mmol/1 MgSO4, 1.2mmol/1 K]-I2PO4, 10mmol/1 Na2HPO4, and 5mg/ml bovine serum albumin, pH 7.5.
Female Sprague Dawley rats, 1300180g, were allowed free access to food and water. They were injected IP with either 1 ~g/g body weight of regular pork insulin (Eli Lilly Co., Indianapolis, IN) or 0.154 tool/1 saline, and killed by decapitation after 0, 10, 30 and 60 rain. Liver plasma membranes were prepared by the method of Ray [9] and stored at -70 ~ Binding studies were performed with 100 gg/ml of plasma membrane protein and 0.3 ng/ ml of labelled 12sI-insulin in the presence or absence of unlabelled hormone at 23 ~ For time course and Scatchard analysis studies, i to 5 ml of incubation mixture was incubated in 17 x 100 Falcon plastic tubes. At various times, 300 gl aliquots were removed, placed into Beckman microfuge tubes and centrifuged at 23 ~ for 1 rain at 10,000 x g. The snpernatants were removed by aspiration, the pellet washed with 300 ~1 of buffer at 4 ~ and the pellet containing bound hormone counted. Nonspecific binding (in the presence of 100 gg of unlabelled hormone) typically was 2-5% of total binding [5] and was subtracted from total binding to yield specific binding. Specific 12SI-glucagon binding was performed in the same manner [5] .
For dissociation studies of ~I-insulin, 1.0 mg/ml of plasma 125 - membrane protein was incubated with 0.6 ng/ml I-insulin for 1 hour in a volume of 50 gl. The mixture was then diluted to 5 ml in 0012-186X/80/0019/0211/$01.00 removed and the plasma membranes again extracted by the same procedure. The two supernatants were then combined, lyophillized, and measured by radioimmunoassay. This procedure extracts 85-100% of the insulin as intact hormone [5] . lzsI-insulin degradation was measured by precipitation in 10% (w/v) trichloroacetic acid [11] . 5'Nucleotidase [12] , protein [13] , and glucose [14] were determined by published techniques.
Results

Insulin and Glucose Values
Injection of rats IP with 1 ~tg/g insulin produced a marked increase in serum insulin levels ( Fig. 1 ) from a pretreatment value of 0.86 + 0.08 ng/ml to a peak of 298 + 48 ng/ml (mean + SEM) 10 min after injection. Sixty min after injection insulin levels were still elevated at 153 + 68ng/ml. At the same time blood glucose values had fallen from a mean value of 128 + 4 mg/dl ( Fig. 1) to 64 + 5 mg/dl after 10 min, with a further fall to 32 + 4 mg/dl after 60 min.
Insulin Binding to Receptors
When purified liver plasma membranes were prepared 10 min after the injection of insulin into rats, lZSI-insulin binding to receptors at steady state had fallen to 59 + 6% (mean + SEM, n = 4) of controls ( Figs. 1-3) ; 60 min after injection binding was at 81 + 8% of controls. This decreased binding was seen throughout the time course of ~25I-insulin binding (Fig. 2) . In contrast, when animals were injected with insulin and studied immediately, insulin binding was the same as that measured in controls injected with 0.154 mol/1 saline (Figs. 1-3 ). Scatchard plots (Fig. 3) were constructed to determine whether the decreased insulin binding was due to a change in either binding affinity or binding capacity. The plots suggested that the major effect of insulin injection was to decrease the insulin binding capacity from approximately 6-7 ng/100 ~tg protein to approximately 3 ng/100 ~tg protein.
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De Meyts has demonstrated that occupancy of insulin receptors by insulin leads to an enhanced rate of hormone dissociation (i. e., negative cooperativity) [15] . Accordingly, to rule out occupation of receptors by exogenous insulin, we bound 125I-insulin to liver plasma membranes obtained from both control rats and rats treated with insulin, and then measured hormone dissociation. No difference in the dissociation of 125I-insulin was noted (Fig. 4) .
Other Studies
Degradation of 125I-insulin was measured by its precipitability in 10% trichloroacetic acid 120 min after incubation with plasma membranes. Control plasma membranes degraded 28.1 + 5.4% (n = 4) of the labelled hormone. In the plasma membranes from insulin-treated animals there was no significant change in insulin degradation; membranes obtained 10 min after insulin injection degraded 23.7 _+ 6.4% of the label and those obtained 30 min after injection degraded 22.9 + 3.3% of the label.
Plasma membranes from both control and insulintreated rats were treated with acetic acid and the extracted insulin measured by radioimmunoassay. Control membranes contained 0.014 + 0.005 ng insulin/100 ~tg of protein; membranes obtained from animals 10 min after injection contained only 0.078 _+ 0.050ng insulin/100 ~tg of protein (Table 1 ). This amount of insulin was approximately 10-20 fold less than the amount of insulin (i. e., 0.5-1.0 ng/100 ~tg protein) needed to cause the observed decrease in the bound/free ratio (Fig. 3) .
5'Nucleotidase activity and specific 125I-glucagon binding were measured on both control plasma membranes and plasma membranes obtained 10 min after insulin injection. There was no significant change in either enzyme activity or glucagon binding (Table 1) .
Discussion
The present studies demonstrate that after the injection of large amounts of insulin IP into normal rats there is a very rapid decrease in insulin binding to its receptors on purified liver plasma membranes. Four lines of evidence indicate that this decrease in binding was not due to either the occupation of receptors by exogenous insulin or changes in the purity of these membranes. First, extraction of plasma membranes revealed that insufficient amounts of insulin were present to account for the lowered binding. Second, Scatchard analyses revealed that the decreased binding was due to a change in binding capacity rather than a change of binding affinity. If the decreased binding was due to contamination, there should have been a change in affinity rather than capacity [6] . Third, dissociation studies provided no evidence of prior occupancy of insulin receptors by injected insulin. Fourth, while insulin binding was decreased, glucagon binding and 5'nucleotidase activity remained unchanged.
These in vivo studies are counterparts to prior in vitro studies which demonstrate that high levels of extracellular insulin can rapidly lower insulin receptor binding [6] . These concentrations of insulin would not normally be encountered in vivo; however, the levels obtained are comparable to those levels of insulin produced in humans by the intravenous injection of high doses of insulin for the treatment of diabetic ketoacidosis [16] . This observation raises the possibility, therefore, that high dose insulin therapy for diabetic ketoacidosis may regulate insulin receptors. In contrast, with low dose insulin therapy for diabetic ketoacidosis, insulin levels remain in the physiologic range [17] and receptors may not be effected.
The mechanism whereby insulin regulates its receptors on the plasma membrane is at present unknown. Studies in vitro suggest that there may be several mechanisms involved in this process. 
